Psyence Biomedical (PBMWW) Competitors $0.02 0.00 (-6.02%) As of 05/30/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock PBMWW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Psyence Biomedical (NASDAQ:PBMWW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations. Does the MarketBeat Community prefer PBMWW or ATNFW? Psyence Biomedical and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPsyence BiomedicalN/AN/A180 Life SciencesN/AN/A Is PBMWW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media refer more to PBMWW or ATNFW? In the previous week, Psyence Biomedical had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Psyence Biomedical and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Psyence Biomedical's score of 0.43 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Psyence Biomedical Neutral 180 Life Sciences Very Positive Which has stronger earnings & valuation, PBMWW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryPsyence Biomedical and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBMWW vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$6.58B$2.00B$8.41BDividend YieldN/A2.63%2.64%4.17%P/E RatioN/A8.7322.6719.79Price / SalesN/A238.3156.90134.17Price / CashN/A65.8551.7234.64Price / BookN/A6.332.054.50Net IncomeN/A$144.21M-$330.96M$248.30M7 Day PerformanceN/A1.06%1.00%0.99%1 Month PerformanceN/A-0.17%6.87%8.02%1 Year PerformanceN/A-2.58%13.98%8.86% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMWWPsyence BiomedicalN/A$0.02-6.0%N/A-65.1%$0.00N/A0.00N/AShort Interest ↑Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.01-6.3%N/A-10.1%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+46.2%N/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.14+16.7%N/A+255.9%$0.00$106,207.000.0040Gap UpALVOWAlvotechN/A$1.80-3.2%N/A-38.9%$0.00$585.60M0.004ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.01-13.4%N/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.11-37.0%N/A+53.3%$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.02-17.3%N/A-94.2%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-22.8%N/A-81.4%$0.00N/A0.008Positive NewsShort Interest ↓CELUWCelularityN/A$0.04-17.2%N/AN/A$0.00$54.22M0.00220Positive NewsGap Up Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBMWW) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBMWW Stock Free PBMWW Stock Alerts